What is Ashley Reed's NPI number?

Ashley Reed's National Provider Identifier (NPI) is 1780842989, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ashley Reed's specialty?

Ashley Reed is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Ashley Reed located?

Ashley Reed's practice location on file with NPPES is 6160 Kempsville Cir, Norfolk, VA 23502-3933.

What is Ashley Reed's phone number?

The practice phone number listed in the NPPES registry for Ashley Reed is (757) 622-6315.

Does Ashley Reed accept Medicare?

Ashley Reed is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ashley Reed's NPI active?

Yes — Ashley Reed's NPI (1780842989) is active in the NPPES registry as of the last update on 2024-06-24.

IndividualActiveAccepts Medicare

Ashley Reed, M.D.

NPI 1780842989 · Dermatology Physician · Norfolk, VA

Ashley Reed, M.D. is a Dermatology Physician provider in Norfolk, VA (NPI 1780842989).

Provider details

NPI number: 1780842989
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: 0101254794 (VA)

Practice location

6160 Kempsville Cir

Suite 200 a

Norfolk, VA 23502-3933

Phone: (757) 622-6315

Fax: (757) 625-6940

Street-level locationGet directions

More VA providers

Mailing address

6160 Kempsville Cir

Norfolk, VA 23502-3933

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101254794 (VA)
Allopathic & Osteopathic Physicians
Dermatopathology Physician207ND0900XLicense 0101254794 (VA)
Allopathic & Osteopathic Physicians

Additional practice locations (1)

1248 Perimeter Pkwy Ste 482
Virginia Beach, VA 23454-5914
Phone: (757) 496-5085

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(95/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
18 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
11,384 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	6,704	$70
Special Stained Specimen Slides to Examine Tissue, Each Additional Procedure88341	1,878	$88
Special Stained Specimen Slides to Examine Tissue, Initial Procedure88342	1,289	$102
Destruction of Precancer Skin Growth, 2-14 Growths17003	513	$6
Special Stained Specimen Slides to Identify Organisms Including Interpretation and Report88312	147	$108
Destruction of Precancer Skin Growth, 1 Growth17000	146

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	50	27
Clobetasol Propionate	36	21
Ammonium Lactate	30	22
Triamcinolone Acetonide	20	16
Mupirocin	19	15
Fluorouracil	18	17
Ciclopirox	17	—
Alclometasone Dipropionate	11	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$849 across 32 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2008-05-26
Last updated: 2024-06-24
Certified: 2024-06-24

Frequently asked questions

What is Ashley Reed's NPI number?: Ashley Reed's National Provider Identifier (NPI) is 1780842989, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ashley Reed's specialty?: Ashley Reed is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Ashley Reed located?: Ashley Reed's practice location on file with NPPES is 6160 Kempsville Cir, Norfolk, VA 23502-3933.
What is Ashley Reed's phone number?: The practice phone number listed in the NPPES registry for Ashley Reed is (757) 622-6315.
Does Ashley Reed accept Medicare?: Ashley Reed is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ashley Reed's NPI active?: Yes — Ashley Reed's NPI (1780842989) is active in the NPPES registry as of the last update on 2024-06-24.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Pathology Examination of Tissue Using a Microscope, Intermediate Complexity88305	6,704	$70
Special Stained Specimen Slides to Examine Tissue, Each Additional Procedure88341	1,878	$88
Special Stained Specimen Slides to Examine Tissue, Initial Procedure88342	1,289	$102
Destruction of Precancer Skin Growth, 2-14 Growths17003	513	$6
Special Stained Specimen Slides to Identify Organisms Including Interpretation and Report88312	147	$108
Destruction of Precancer Skin Growth, 1 Growth17000	146

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

Clobetasol Propionate

Ammonium Lactate

Triamcinolone Acetonide

Mupirocin

Fluorouracil

Ciclopirox

—

Alclometasone Dipropionate

—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$849 across 32 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments